[Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
A phenol insoluble extract vaccine proposed to immunize men against brucellosis was tested for its ability in protecting guinea pigs against challenge with virulent Brucella abortus strain 2308. Living attenuated Brucella abortus strain 19 and B. melitensis Rev. 1 were included in the experiment for comparison. Ninety three animals were vaccinated in each group and subdivided in subgroups of 31 for challenge with 10(4), 10(3) and 10(2) colony forming units of virulent B. abortus 2308. A global analysis of the results showed protection of 11.9%, 65% and 95% in animals vaccinated with phenol insoluble extract, strain 19 and Rev. 1, respectively.
Bolpe
J
J
Departamento de Zoonosis Rurales, Provincia de Buenos Aires, Argentina.
de Lapenta
D F
DF
García-Carrillo
C
C
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology*; D001835:Body Weight; D002004:Brucella Vaccine / Q000276:immunology*; D002003:Brucella abortus / Q000276:immunology* / Q000472:pathogenicity; D017347:Brucella melitensis / Q000276:immunology; D002006:Brucellosis / Q000276:immunology / Q000517:prevention & control*; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D008297:Male; D010636:Phenols; D014774:Virulence
D000942:Antigens, Bacterial; D002004:Brucella Vaccine; D010636:Phenols
Vacuna fenol-insoluble contra la brucelosis humana: evaluación del poder inmunogénico en cobayos.